Expert Interviews

September 15, 2020

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.

July 31, 2020

Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring (CGM) technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.

July 29, 2020

In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

July 22, 2020

Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

July 14, 2020

In part 2 of our interview, Dr. Cheryl Wisseh, PharmD, MPH, zone 5 director, NPhA, dives into the forces that bring about racial disparities, and offers pharmacy and health system-centered solutions.

July 10, 2020

Dr. Cheryl Wisseh, PharmD, zone 5 director of the National Pharmaceutical Association (NPhA) discusses the ways that the current pandemic is displaying and doubling down on long standing disparities in our health care system.

July 07, 2020

Drug Topics interviews Steve Mok, PharmD, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence can mitigate challenges posed by the COVID-19 pandemic.

July 03, 2020

Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.

June 29, 2020

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

June 25, 2020

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.